globalequitygroup
Somx
I don't think you are a basher, but I would like to know what gave you pause in your evaluation of Silenor.
I notice on the Wire about the CRL, that they did not indicate that the drug had met the long term efficacy req. for the "non elderly" population.
This is the only thing that I can see that would cause a decline. Everything else seems to be inline with an approval.
1. No New Safety Concerns
2. QT Interval concerns from the 1mg dose was removed
3. Long Term (1 month efficacy) on elderly pop.
What else could it have been.
As I watch the stock, I see that it has moved up from its gapped down morning lows. There is some buying going on here. A lot actually.
I was thinking this thing would go sub .50. But its obviously not today.
I got in @ 2.25 and got out @ 3.45.
When there was no news on Friday...I stayed out. Thankfully.
Somaxon has to get an approval by Summer or they are TOAST.
They have already said that they have enough money to make it through 1st half of 2010.
I think they are going to do everything in their power to get approval.
This makes me think twice I must say.
IF they get a meeting with the FDA and things start to look up, it may be a good stock to ride again.
Could this be a bargain buy here? Only time will tell.